Arcturus Therapeutics

About:

Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.

Website: http://arcturusrx.com

Twitter/X: arcturusrx

Top Investors: Biomedical Advanced Research and Development Authority (BARDA), Cystic Fibrosis Foundation, Japan - The Government of Japan

Description:

Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome. It was founded in 2013 and is headquartered in San Diego, California.